Actualités 2023/12/19 Les Grands Titres de Suisse occidentale (Octobre-Décembre 2023) De l’obtention des meilleurs classements en matière d’innovation mondiale à la réalisation d’avancées significatives dans les domaines de la sant...
Actualités 2023/10/20 Lonza s’agrandit pour fabriquer le vaccin pneumococcique conjugué de Vaxcyte Lonza et la société américaine Vaxcyte, spécialisée dans l’innovation vaccinale de stade clinique, ont annoncé le renforcement de leur partenaria...
Actualités 2023/09/29 Les Grands Titres de Suisse occidentale (Juillet-Septembre 2023) De l'élaboration de solutions éco-innovantes à des avancées pionnières dans les domaines de la technologie solaire, de la recherche sur le cancer...
News 2023/12/11 Cytiva’s strategic expansion in Western Switzerland’s Health Valley Cytiva, a global life sciences leader, has recently bolstered its operations in the Health Valley through a strategic merger with Pall Life Scien...
News 2023/12/19 Top Stories from Western Switzerland (October-December 2023) From achieving top rankings in global innovation to making significant advancements in healthcare and technology, discover Western Switzerland's ...
News 2023/12/11 Artbio and Scailyte making headlines in Basel The biotech company Scailyte has raised 8 million US dollars as part of a Series A financing round. For its part, Artbio has raised as much as 90...
Actualités 2023/07/04 Les Grands Titres de Suisse occidentale (Avril-Juin 2023) De l’exploration spatiale aux percées médicales en passant par des avancées dans les domaines de la formation et des technologies, découvrez les ...
Aktuell 2023/10/10 MSD bekennt sich zum Standort Luzern MSD Schweiz will von Luzern aus weiter wachsen. Seit seiner Gründung vor 60 Jahren hat das Pharmaunternehmen kantonsweit eine halbe Milliarde Fr...
News 2023/11/03 EPFL and Novochizol to collaborate on designing more efficient immunotherapies A groundbreaking collaboration between EPFL's Laboratory of Biomaterials for Immunoengineering and Novochizol aims to revolutionize cancer treatm...
News 2023/10/20 Lonza expands to manufacture Vaxcyte’s pneumococcal conjugate vaccine Lonza and US clinical-stage vaccine innovation company Vaxcyte have announced an expansion in their partnership to establish a global commercial ...
News 2023/10/18 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
News 2023/10/04 Atinary Technologies raises USD 5 million to accelerate material and molecular innovation Vaud-based machine learning specialist Atinary Technologies has raised USD 5 million, propelling the start-up towards a new era of material and m...
News 2023/10/10 HES-SO Valais-Wallis and Debiopharm partner up to battle cancer HES-SO Valais-Wallis and Debiopharm have entered a partnership to advance targeted cancer therapy research with novel antibody conjugates.
News 2023/09/29 Top Stories from Western Switzerland (July-September 2023) From spearheading eco-innovative solutions to pioneering breakthroughs in solar technology, cancer research, sustainable shipping, and the realms...
Aktuell 2023/06/28 Clear Solutions Labs will von Standort Basel profitieren Die Gründer der Clear Solutions Laboratories stellen in Basel ein Team von Fachleuten in Biotechnologie, Pharmazie und analytischer Biochemie zu...